Front Neurosci. 2015 May 27;9:117. doi: 10.3389/fnins.2015.00117. eCollection 2015.
The role of the autonomic nervous system in Tourette Syndrome.
Frontiers in neuroscience
Jack Hawksley, Andrea E Cavanna, Yoko Nagai
Affiliations
Affiliations
- North Essex Partnership University NHS Foundation Trust Colchester, UK.
- Department of Neuropsychiatry, Birmingham and Solihull Mental Health NHS Trust and School of Clinical and Experimental Medicine, University of Birmingham Birmingham, UK.
- Department of Clinical Medicine, Clinical Imaging Sciences Center, Brighton and Sussex Medical School, University of Sussex Brighton, UK ; Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London London, UK.
PMID: 26074752
PMCID: PMC4444819 DOI: 10.3389/fnins.2015.00117
Abstract
Tourette Syndrome (TS) is a neurodevelopmental disorder, consisting of multiple involuntary movements (motor tics) and one or more vocal (phonic) tics. It affects up to one percent of children worldwide, of whom about one third continue to experience symptoms into adulthood. The central neural mechanisms of tic generation are not clearly understood, however recent neuroimaging investigations suggest impaired cortico-striato-thalamo-cortical activity during motor control. In the current manuscript, we will tackle the relatively under-investigated role of the peripheral autonomic nervous system, and its central influences, on tic activity. There is emerging evidence that both sympathetic and parasympathetic nervous activity influences tic expression. Pharmacological treatments which act on sympathetic tone are often helpful: for example, Clonidine (an alpha-2 adrenoreceptor agonist) is often used as first choice medication for treating TS in children due to its good tolerability profile and potential usefulness for co-morbid attention-deficit and hyperactivity disorder. Clonidine suppresses sympathetic activity, reducing the triggering of motor tics. A general elevation of sympathetic tone is reported in patients with TS compared to healthy people, however this observation may reflect transient responses coupled to tic activity. Thus, the presence of autonomic impairments in patients with TS remains unclear. Effect of autonomic afferent input to cortico-striato-thalamo-cortical circuit will be discussed schematically. We additionally review how TS is affected by modulation of central autonomic control through biofeedback and Vagus Nerve Stimulation (VNS). Biofeedback training can enable a patient to gain voluntary control over covert physiological responses by making these responses explicit. Electrodermal biofeedback training to elicit a reduction in sympathetic tone has a demonstrated association with reduced tic frequency. VNS, achieved through an implanted device that gives pulsatile electrical stimulation to the vagus nerve, directly modulates afferent interoceptive signals. The potential efficacy of biofeedback/VNS in TS and the implications for understanding the underlying neural mechanisms of tics will be discussed.
Keywords: Tourette Syndrome; autonomic modulation; autonomic nervous system; sympathetic activity; ticks
References
- J Psychosom Res. 2009 Dec;67(6):599-605 - PubMed
- Mov Disord. 1987;2(2):99-102 - PubMed
- J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1320-3 - PubMed
- Neurology. 1982 Nov;32(11):1315-7 - PubMed
- Pediatr Neurol. 1998 Feb;18(2):136-42 - PubMed
- Adv Neurol. 1982;35:391-401 - PubMed
- Behav Neurol. 2013;27(1):65-73 - PubMed
- Pediatr Neurosci. 1985-1986;12(2):71-4 - PubMed
- Neurosci Biobehav Rev. 2013 Jul;37(6):1008-15 - PubMed
- J Clin Psychiatry. 1992 Sep;53(9):319-23 - PubMed
- J Psychosom Res. 2008 Nov;65(5):473-86 - PubMed
- Adv Pharmacol. 2013;68:319-34 - PubMed
- Pediatr Neurol. 2009 Jun;40(6):420-5 - PubMed
- Am J Psychiatry. 1977 Mar;134(3):257-60 - PubMed
- Am J Psychiatry. 2011 Dec;168(12):1326-37 - PubMed
- J Neurol Neurosurg Psychiatry. 1985 Jun;48(6):535-44 - PubMed
- Br J Psychiatry. 2008 Jul;193(1):31-6 - PubMed
- Neuron. 2013 Feb 20;77(4):624-38 - PubMed
- J Psychosom Res. 2008 Nov;65(5):461-72 - PubMed
- Psychiatry Res. 2013 Dec 30;210(3):1198-204 - PubMed
- J Am Acad Child Psychiatry. 1986 Sep;25(5):645-52 - PubMed
- Brain Dev. 2014 Jan;36(1):45-50 - PubMed
- Behav Res Ther. 1988;26(4):347-51 - PubMed
- Trends Neurosci. 2006 Mar;29(3):175-82 - PubMed
- Eur Neuropsychopharmacol. 2007 Jul;17(8):523-6 - PubMed
- Psychol Rep. 1998 Oct;83(2):515-29 - PubMed
- Ann N Y Acad Sci. 2011 Jan;1216:86-98 - PubMed
- Mov Disord. 2006 Aug;21(8):1273-5 - PubMed
- Neurology. 1997 Feb;48(2):358-62 - PubMed
- Neurol Clin. 1997 May;15(2):267-75 - PubMed
- Adv Neurol. 1992;58:245-51 - PubMed
- Biol Psychiatry. 1994 Jul 1;36(1):35-43 - PubMed
- Clin Neuropharmacol. 2012 Nov-Dec;35(6):269-72 - PubMed
- J Psychosom Res. 2009 Dec;67(6):475-83 - PubMed
- Brain. 2000 Mar;123 Pt 3:425-62 - PubMed
- Adv Neurol. 2001;85:113-22 - PubMed
- Int Rev Neurobiol. 2013;112:239-79 - PubMed
- Mov Disord. 2003 Nov;18(11):1392-5 - PubMed
- Cogn Behav Neurol. 2014 Mar;27(1):17-24 - PubMed
- Funct Neurol. 2012 Jan-Mar;27(1):23-7 - PubMed
- J Clin Psychiatry. 1990 Nov;51(11):463-9 - PubMed
- Compr Psychiatry. 2013 Jul;54(5):462-6 - PubMed
- Arch Gen Psychiatry. 1980 Dec;37(12):1350-7 - PubMed
- Pharmacopsychiatry. 2008 May;41(3):117-8 - PubMed
- Arch Gen Psychiatry. 1991 Apr;48(4):324-8 - PubMed
- Clin Neurol Neurosurg. 1992;94(2):157-9 - PubMed
- Compr Psychiatry. 2013 Jul;54(5):467-73 - PubMed
Publication Types